Key result
CRT-D enables complete inotrope weaning and functional recovery in inotrope-dependent patients intolerant to GDMT.
Why the study?
Does salvage CRT-D implantation improve functional status and enable weaning from inotropic support in patients with advanced HFrEF and LBBB who are unable to tolerate GDMT?
Case Report (n=2)
Does salvage CRT-D implantation improve functional status and enable weaning from inotropic support in patients with advanced HFrEF and LBBB who are unable to tolerate GDMT?
CRT-D may serve as a successful salvage or enabling therapy in select inotrope-dependent patients with advanced HFrEF and LBBB who cannot complete the guideline-recommended 3-month GDMT optimization period.
Answers are grounded in this paper and cite their sources.
May support CRT-D rescue in select inotrope-dependent HFrEF with LBBB; leaves open need for prospective trials before any practice change.
Current ACC/AHA/HFSA guidelines endorse cardiac resynchronization therapy with defibrillation (CRT-D) as a Class I recommendation for patients with heart failure with reduced ejection fraction (HFrEF), left bundle branch block (LBBB), and QRS ≥150 ms but only after at least three months of maximally tolerated guideline-directed medical therapy (GDMT). A critical and under-addressed clinical scenario exists - patients with electromechanical dyssynchrony who cannot achieve GDMT optimization due to hypotension, renal dysfunction, or inotrope dependence. Current guidelines do not provide a recommendation pathway for this population, leaving clinicians without evidence-based guidance in a high-stakes decision context. We present two patients with advanced non-ischemic cardiomyopathy, LBBB with markedly prolonged QRS duration (166-168 ms), and LVEF <20%, both of whom were inotrope-dependent and unable to tolerate GDMT. Neither met traditional prerequisites for CRT-D implantation. Following multidisciplinary evaluation, both patients underwent successful CRT-D implantation, were weaned from intravenous inotropic support, improved from NYHA Class IV to Class II at one year, and had no heart failure hospitalizations during follow-up, with meaningful gains in LVEF in both cases. CRT-D may serve as a salvage or enabling therapy in select patients with advanced HFrEF and electrical dyssynchrony who are unable to complete the recommended GDMT optimization period. Prospective studies are needed to refine selection criteria in this high-risk population.
No takes yet. Share an insight, caveat, or question.
Srikanth et al. (2026) conducted a case report in Advanced non-ischemic cardiomyopathy with HFrEF and LBBB (n=2). Cardiac resynchronization therapy with defibrillation (CRT-D) implantation was evaluated on Weaning from intravenous inotropic support, NYHA functional class improvement, heart failure hospitalizations, and LVEF improvement at 1 year. CRT-D implantation in 2 inotrope-dependent patients unable to tolerate GDMT enabled 100% inotrope weaning, improvement from functional class IV to II, and 0 HF hospitalizations at 1 year.
Synapse has enriched 10 related papers. Consider them for comparative context: